Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review

IF 3.9 2区心理学 Q1 PSYCHIATRY

European Eating Disorders Review Pub Date : 2024-05-23 DOI:10.1002/erv.3101

Karolina Cuerva, Dean Spirou, Adrian Cuerva, Chantal Delaquis, Jayanthi Raman

{"title":"Perspectives and preliminary experiences of psychedelics for the treatment of eating disorders: A systematic scoping review","authors":"Karolina Cuerva, Dean Spirou, Adrian Cuerva, Chantal Delaquis, Jayanthi Raman","doi":"10.1002/erv.3101","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>Research regarding the therapeutic application of psychedelics and psychedelic-assisted psychotherapy in the treatment of eating disorders (EDs) has begun to emerge. This systematic scoping review aimed to map and synthesise the existing evidence regarding the participant reported efficacy and perspectives concerning psychedelics in the treatment of EDs, and to identify significant research gaps.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>A systematic search was undertaken across several databases in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guidelines.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>1290 publications were identified, 1135 after duplicates removed, with 17 meeting full-eligibility criteria. Overall, findings suggested that most participants reported experiencing a meaningful reduction in their ED symptoms and having positive experiences or an openness to explore psychedelics as a treatment for ED symptoms, although some noted concerns of adverse effects and the importance of having psychological support to increase safety and efficacy.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>While preliminary research suggests psychedelics and psychedelic-assisted psychotherapy may be a viable treatment option for ED symptoms, further research with more robust research designs is required to increase confidence in its efficacy, generalisability, and safety as a therapeutic medium.</p>\n </section>\n </div>","PeriodicalId":48117,"journal":{"name":"European Eating Disorders Review","volume":"32 5","pages":"980-1001"},"PeriodicalIF":3.9000,"publicationDate":"2024-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/erv.3101","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Eating Disorders Review","FirstCategoryId":"102","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/erv.3101","RegionNum":2,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective

Research regarding the therapeutic application of psychedelics and psychedelic-assisted psychotherapy in the treatment of eating disorders (EDs) has begun to emerge. This systematic scoping review aimed to map and synthesise the existing evidence regarding the participant reported efficacy and perspectives concerning psychedelics in the treatment of EDs, and to identify significant research gaps.

Method

A systematic search was undertaken across several databases in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews guidelines.

Results

1290 publications were identified, 1135 after duplicates removed, with 17 meeting full-eligibility criteria. Overall, findings suggested that most participants reported experiencing a meaningful reduction in their ED symptoms and having positive experiences or an openness to explore psychedelics as a treatment for ED symptoms, although some noted concerns of adverse effects and the importance of having psychological support to increase safety and efficacy.

Conclusions

While preliminary research suggests psychedelics and psychedelic-assisted psychotherapy may be a viable treatment option for ED symptoms, further research with more robust research designs is required to increase confidence in its efficacy, generalisability, and safety as a therapeutic medium.

Abstract Image

查看原文本刊更多论文

迷幻剂治疗饮食失调症的观点和初步经验：系统性的范围综述。

目的：有关迷幻药和迷幻药辅助心理疗法在饮食失调症（EDs）治疗中的应用的研究已经开始出现。本系统性范围界定综述旨在绘制和综合现有证据，这些证据涉及参与者报告的迷幻剂在治疗饮食失调症方面的疗效和观点，并找出重要的研究缺口：方法：根据《系统综述和Meta分析的首选报告项目》（Preferred Reporting Items for Systematic Review and Meta-Analyses extension for Scoping Reviews）指南，在多个数据库中进行了系统检索：共发现 1290 篇出版物，去除重复内容后为 1135 篇，其中 17 篇符合完全合格标准。总体而言，研究结果表明，大多数参与者都报告说他们的性欲减退症状明显减轻，并有积极的体验或愿意探索将迷幻药作为治疗性欲减退症状的方法，但也有一些人指出了对不良反应的担忧以及获得心理支持以提高安全性和有效性的重要性：尽管初步研究表明，迷幻药和迷幻药辅助心理疗法可能是治疗ED症状的一种可行方法，但还需要进行更深入的研究，采用更稳健的研究设计，以增强人们对其作为一种治疗手段的疗效、普遍性和安全性的信心。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European Eating Disorders Review PSYCHOLOGY, CLINICAL-

CiteScore

8.90

自引率

7.50%

发文量

期刊介绍： European Eating Disorders Review publishes authoritative and accessible articles, from all over the world, which review or report original research that has implications for the treatment and care of people with eating disorders, and articles which report innovations and experience in the clinical management of eating disorders. The journal focuses on implications for best practice in diagnosis and treatment. The journal also provides a forum for discussion of the causes and prevention of eating disorders, and related health policy. The aims of the journal are to offer a channel of communication between researchers, practitioners, administrators and policymakers who need to report and understand developments in the field of eating disorders.